180 related articles for article (PubMed ID: 22232690)
1. Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasis.
Cummings HE; Barbi J; Reville P; Oghumu S; Zorko N; Sarkar A; Keiser TL; Lu B; Rückle T; Varikuti S; Lezama-Davila C; Wewers MD; Whitacre C; Radzioch D; Rommel C; Seveau S; Satoskar AR
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1251-6. PubMed ID: 22232690
[TBL] [Abstract][Full Text] [Related]
2. PI3K-γ inhibitors in the therapeutic intervention of diseases caused by obligate intracellular pathogens.
Oghumu S; Satoskar AR
Commun Integr Biol; 2013 Mar; 6(2):e23360. PubMed ID: 23749323
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphatidylinositol-3-kinase-gamma (PI3Kgamma)-mediated pathway in 17beta-estradiol-induced killing of L. mexicana in macrophages from C57BL/6 mice.
Lezama-Dávila CM; Isaac-Márquez AP; Barbi J; Cummings HE; Lu B; Satoskar AR
Immunol Cell Biol; 2008; 86(6):539-43. PubMed ID: 18542100
[TBL] [Abstract][Full Text] [Related]
4. Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion.
Hurrell BP; Schuster S; Grün E; Coutaz M; Williams RA; Held W; Malissen B; Malissen M; Yousefi S; Simon HU; Müller AJ; Tacchini-Cottier F
PLoS Pathog; 2015 May; 11(5):e1004929. PubMed ID: 26020515
[TBL] [Abstract][Full Text] [Related]
5. Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice.
Siragusa M; Katare R; Meloni M; Damilano F; Hirsch E; Emanueli C; Madeddu P
Circ Res; 2010 Mar; 106(4):757-68. PubMed ID: 20056919
[TBL] [Abstract][Full Text] [Related]
6. Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes.
Fougerat A; Gayral S; Gourdy P; Schambourg A; Rückle T; Schwarz MK; Rommel C; Hirsch E; Arnal JF; Salles JP; Perret B; Breton-Douillon M; Wymann MP; Laffargue M
Circulation; 2008 Mar; 117(10):1310-7. PubMed ID: 18268153
[TBL] [Abstract][Full Text] [Related]
7. Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection.
Maus UA; Backi M; Winter C; Srivastava M; Schwarz MK; Rückle T; Paton JC; Briles D; Mack M; Welte T; Maus R; Bohle RM; Seeger W; Rommel C; Hirsch E; Lohmeyer J; Preissner KT
Am J Respir Crit Care Med; 2007 May; 175(9):958-66. PubMed ID: 17322108
[TBL] [Abstract][Full Text] [Related]
8. Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance.
Kobayashi N; Ueki K; Okazaki Y; Iwane A; Kubota N; Ohsugi M; Awazawa M; Kobayashi M; Sasako T; Kaneko K; Suzuki M; Nishikawa Y; Hara K; Yoshimura K; Koshima I; Goyama S; Murakami K; Sasaki J; Nagai R; Kurokawa M; Sasaki T; Kadowaki T
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5753-8. PubMed ID: 21436039
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase gamma required for lipopolysaccharide-induced transepithelial neutrophil trafficking in the lung.
Reutershan J; Saprito MS; Wu D; Rückle T; Ley K
Eur Respir J; 2010 May; 35(5):1137-47. PubMed ID: 19797129
[TBL] [Abstract][Full Text] [Related]
10. Frontline Science:
Hurrell BP; Beaumann M; Heyde S; Regli IB; Müller AJ; Tacchini-Cottier F
J Leukoc Biol; 2017 Nov; 102(5):1187-1198. PubMed ID: 28798144
[TBL] [Abstract][Full Text] [Related]
11. The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.
Azzi J; Moore RF; Elyaman W; Mounayar M; El Haddad N; Yang S; Jurewicz M; Takakura A; Petrelli A; Fiorina P; Ruckle T; Abdi R
Diabetes; 2012 Jun; 61(6):1509-18. PubMed ID: 22403300
[TBL] [Abstract][Full Text] [Related]
12. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
Nabors GS; Farrell JP
Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
14. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.
Hepburn NC; Tidman MJ; Hunter JA
Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779
[TBL] [Abstract][Full Text] [Related]
15. The effect of pharmacological PI3Kγ inhibitor on eotaxin-induced human eosinophil functions.
Saito Y; Takeda M; Nishikawa J; Konno Y; Tamaki M; Itoga M; Kobayashi Y; Moritoki Y; Ito W; Chihara J; Ueki S
Pulm Pharmacol Ther; 2014 Apr; 27(2):164-9. PubMed ID: 24333185
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells.
Dutra RC; Cola M; Leite DF; Bento AF; Claudino RF; Nascimento AF; Leal PC; Calixto JB
Br J Pharmacol; 2011 May; 163(2):358-74. PubMed ID: 21244371
[TBL] [Abstract][Full Text] [Related]
17. Th17 cells and neutrophils: Close collaborators in chronic Leishmania mexicana infections leading to disease severity.
Pedraza-Zamora CP; Delgado-Domínguez J; Zamora-Chimal J; Becker I
Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28207936
[TBL] [Abstract][Full Text] [Related]
18. PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis.
Comerford I; Litchfield W; Kara E; McColl SR
PLoS One; 2012; 7(9):e45095. PubMed ID: 23028778
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis.
Gomes CM; Goto H; Ribeiro Da Matta VL; Laurenti MD; Gidlund M; Corbett CE
Int J Exp Pathol; 2000 Aug; 81(4):249-55. PubMed ID: 10971746
[TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.
Navin TR; Arana BA; Arana FE; Berman JD; Chajón JF
J Infect Dis; 1992 Mar; 165(3):528-34. PubMed ID: 1311351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
